Aims & Scope

European Health & Pharmaceutical Law Review - EHPL.

As of Issue 1/2022 the »European Pharmaceutical Law Review« (EPLR) will be known as the »European Health and Pharma Law Review« (EHPL).

Although we have focussed on the pharmaceutical sector over the last 5 years, we have been had the opportunity to publish cutting edge research from across the health law space.

This has included contributions on medical devices, artificial intelligence, digital health and big data.

Our new title more accurately reflects this content as well as the scope and purpose of the journal; namely to provide a forum for discussion on the latest legal developments in the health and pharmaceutical sectors.

The European Health & Pharmaceutical Law Review (EHPL) identifies and analyses important legal and regulatory developments on the national, EU and international level.

Furthermore, it provides an overview of and critically examines judgments that shape the interpretation and application of EU pharmaceutical law and policy, in particular those by the European Courts, international courts and tribunals such as the WTO's Dispute Settlement Body, and higher national courts.

View Aims & Scope

Metrics & Ranking

SJR (SCImago Journal Rank)

Year Value
2024 0.106

Quartile

Year Value
2024 Q4

h-index

Year Value
2024 1

Journal Rank

Year Value
2024 28975

Journal Citation Indicator

Year Value
2024 1

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.


Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Pharmacology, Toxicology and Pharmaceutics and Social Sciences, designed to support cutting-edge academic discovery.


Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.


SJR (SCImago Journal Rank)

SJR
0.106
First Published: 2024

Quartile

Current Quartile
Q4
First Published: 2024

Similar Journals

Top Journals in Related Fields